USPTO serial 79192812
LUMIRATEK
Reviewed by CopyMark Law Group
Reg. 5268376Status 404
- Filing date
- Status date
- Registration date
- Aug 22, 2017
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LUMIRATEK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy M. Kenny
Timothy M. Kenny Norton Rose Fulbright US LLP98 San Jacinto Boulevard, Suite 1100c/o Trademark Docketing Dept.Austin, TX 78701-4255Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Diagnostic, examination and monitoring equipment for medical purposes, namely, apparatus for the detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; medical diagnostic apparatus for the detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse medical diagnostic instruments for detecting chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; diagnostic instruments for medical use for the testing and analysis of assays; electronic apparatus for medical purposes for the monitoring of glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; analytical instruments for medical use, namely device for monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; apparatus for carrying-out diagnostic tests for medical purposes, namely measurement and detection of glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; medical apparatus for monitoring vital signs; apparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; diagnostic imaging apparatus for medical use; diagnostic measuring apparatus for medical use, namely device for monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, and vital signs, blood counts and blood analysis; apparatus for blood analysis for medical purposes; medical instruments for drug abuse testing; medical imaging apparatus; medical apparatus for detecting drugs of abuse; medical apparatus for detecting and measuring the level of substances in bodily fluids; and parts and fittings for all the aforesaid goods, included in the class | SECTION 71 - CANCELLED | — |
| 035 | Compilation of medical reports into computer databases | SECTION 71 - CANCELLED | — |
| 044 | Healthcare services; medical services; medical diagnostic testing and reporting services; providing medical information, consultation and advisory services; consulting services in the field of health; medical consulting regarding medical diagnostic apparatus and instruments; medical consulting regarding diagnostic preparations; surgical diagnostic services; advice relating to the medical needs of elderly people; providing medical advisory services relating to medical instruments; providing medical advisory services relating to medical services; conducting of medical examinations; medical analysis services, namely, providing medical record analysis and assessment services designed to provide patients and healthcare professionals with customized diagnostic information, patient diagnoses, medical treatment plans and healthcare management plans; medical examination of individuals; medical health assessment services; medical screening; medical services for the diagnosis of conditions of the human body; medical testing for diagnostic purposes; surgical diagnostic services; health and medical services delivered via online interactive database enabling medical device users to exchange information with healthcare providers; and advice, consultancy and information on the aforesaid, included in the class | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Roche Diagnostics International AG
- Other trademarks owned by LUMIRADX INTERNATIONAL LTD
- Other trademarks owned by LUMIRADX INTERNATIONAL LTD
- Other trademarks owned by LUMIRADX INTERNATIONAL LTD
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named LUMIRATEK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Sep 10, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 21, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 26, 2024 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Nov 26, 2024 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 22, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 9, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 8, 2024 | C71T | CANCELLED SECTION 71 | — |
| Aug 22, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 13, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 3, 2021 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Dec 20, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 22, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 6, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 6, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 22, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 22, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2017 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 7, 2017 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Jun 6, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 6, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 17, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 1, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 29, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 18, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 3, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 3, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 30, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 13, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 12, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 11, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 6, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 6, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |